Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/25 20:33 | 3/3/25 | IOVA | Health | BioPrd | Biological Products, (No Diag | Bellemin Jean-Marc | CA | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 59 | 56 | D | |||||||||||||||
3/5/25 20:32 | 3/3/25 | IOVA | Health | BioPrd | Biological Products, (No Diag | Bilinsky Igor | CA | O | COO | 2 | M.d | 0 | 0.00 | 0 | 65 | 287 | 88 | D | ||||||||||||||
3/5/25 20:32 | 3/3/25 | IOVA | Health | BioPrd | Biological Products, (No Diag | Vogt Frederick G | CA | DO | Interim | 2 | M.d | 0 | 0.00 | 0 | 245 | 233 | 350 | D | ||||||||||||||
3/5/25 20:31 | 3/3/25 | IOVA | Health | BioPrd | Biological Products, (No Diag | Puri Raj K. | CA | O | Chief Re | 2 | M.d | 0 | 0.00 | 0 | 68 | 54 | 195 | D | ||||||||||||||
3/5/25 20:30 | 3/3/25 | IOVA | Health | BioPrd | Biological Products, (No Diag | Graf Finckenstein Friedrich | CA | O | Chief Me | 2 | M.d | 0 | 0.00 | 0 | 65 | 237 | 93 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |